Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Cell Death and Differentiation
|
March 14, 2025
Neutralization of acyl CoA binding protein (ACBP) for the experimental treatment of osteoarthritis
Uxía Nogueira-Recalde, Flavia Lambertucci, Léa Montégut, et al.
Cancer Research
|
December 5, 2013
CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy
Yuting Ma, Stephen R Mattarollo, Sandy Adjemian, et al.
Autophagy
|
December 12, 2024
Lysosomal damage due to cholesterol accumulation triggers immunogenic cell death
Karla Alvarez-Valadez, Allan Sauvat, Julien Diharce, et al.
Immunological Reviews
|
October 14, 2017
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance
Norma Bloy, Pauline Garcia, Céline M Laumont, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2023
New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma
Maria Perez-Lanzon, Vincent Carbonnier, Pierre Cordier, et al.
Oncoimmunology
|
December 8, 2018
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer
Alexandre Ivagnès, Meriem Messaoudene, Gautier Stoll, et al.
Cell Death and Differentiation
|
January 20, 2025
Epigenetic regulation of HOXA2 expression affects tumor progression and predicts breast cancer patient survival
Fatima Domenica Elisa De Palma, Jonathan G Pol, Vincent Carbonnier, et al.
Journal for Immunotherapy of Cancer
|
June 24, 2021
Metabolic features of cancer cells impact immunosurveillance
Adrien Joseph, Pan Juncheng, Michele Mondini, et al.
Nature Communications
|
September 18, 2020
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Aitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Nature Communications
|
August 1, 2020
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Aitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Cell Death and Differentiation
|
March 14, 2025
Neutralization of acyl CoA binding protein (ACBP) for the experimental treatment of osteoarthritis
Uxía Nogueira-Recalde, Flavia Lambertucci, Léa Montégut, et al.
Cancer Research
|
December 5, 2013
CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy
Yuting Ma, Stephen R Mattarollo, Sandy Adjemian, et al.
Autophagy
|
December 12, 2024
Lysosomal damage due to cholesterol accumulation triggers immunogenic cell death
Karla Alvarez-Valadez, Allan Sauvat, Julien Diharce, et al.
Immunological Reviews
|
October 14, 2017
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance
Norma Bloy, Pauline Garcia, Céline M Laumont, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2023
New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma
Maria Perez-Lanzon, Vincent Carbonnier, Pierre Cordier, et al.
Oncoimmunology
|
December 8, 2018
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer
Alexandre Ivagnès, Meriem Messaoudene, Gautier Stoll, et al.
Cell Death and Differentiation
|
January 20, 2025
Epigenetic regulation of HOXA2 expression affects tumor progression and predicts breast cancer patient survival
Fatima Domenica Elisa De Palma, Jonathan G Pol, Vincent Carbonnier, et al.
Journal for Immunotherapy of Cancer
|
June 24, 2021
Metabolic features of cancer cells impact immunosurveillance
Adrien Joseph, Pan Juncheng, Michele Mondini, et al.
Nature Communications
|
September 18, 2020
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Aitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Nature Communications
|
August 1, 2020
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Aitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Page
of 6